Perioperative Management after High-Dose Chemotherapy with Autologous or Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors

Conclusions Our data indicate that surgical treatment can be safely performed even after HDC with HSCT if attention is paid to myelosuppression and the adverse effects of both chemotherapeutic agents and immunosuppressants.[...]Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents  |  Abstract  |  Full text

Source: European Journal of Pediatric Surgery - August 11, 2014 Category: Surgery Authors: Uehara, ShuichiroOue, TakaharuNakahata, KengoNara, KeigoUeno, TakehisaOwari, MitsuguUsui, NoriakiMiyamura, TakakoHashii, Yoshiko Tags: Original Article Source Type: research